Management of Barrett's esophagus

ONCOLOGY

Volumn 21, Issue 11, 2007, Pages 1382-1392

  Schuchert, Matthew J ^a   Luketich, James D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PHOTOFRIN; PROTON PUMP INHIBITOR; RANITIDINE; STEROID; STOMACH SECRETION INHIBITOR;

ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CANCER MORTALITY; CANCER RISK; CAUCASIAN; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COLUMNAR EPITHELIUM; CONSENSUS DEVELOPMENT; DISEASE DURATION; DISEASE MARKER; DISEASE SURVEILLANCE; DRUG MECHANISM; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; GOBLET CELL; HIGH RISK PATIENT; HUMAN; MORNING DOSAGE; OBESITY; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SMOKING; SQUAMOUS EPITHELIUM; STOMACH FUNDOPLICATION; TREATMENT INDICATION; PATHOLOGY; REVIEW;

BARRETT ESOPHAGUS; CLINICAL TRIALS AS TOPIC; HUMANS;

EID: 39749108850     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Tileston W: Peptic ulcer of the esophagus. Am J Med Sci 132:240-265, 1906.
2. Barrett's NR: Chronic peptic ulcer of the esophagus and "oesophagitis." Br J Surg 38:175-182, 1950.
3. Boscher LH, Taylor FH: Heterotopic gastric mucosa in the esophagus with ulceration and stricture formation. J Thorac Surg 21:306-312, 1951.
4. Moersch RN, Ellis FH, McDonald JR: Pathologic changes occurring in severe reflux esophagitis. Surg Gynecol Obstet 108:476-484, 1959.
5. Cameron AJ, Lomboy CT, Pera M, et al: Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 109:1541-1546, 1995.
6. Shaheen NJ, Crosby MA, Bozymski EM, et al: Is there publication bias in reporting cancer risk in Barrett's esophagus? Gastroenterology 119:333-338, 2000.
7. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998.
8. Peters JH, DeMeester TR: Esophagus: Anatomy, physiology and gastroesophageal reflux disease, in Greenfield LJ, Mulholland MW, Oldham KT, et al (eds): Surgery: Scientific Principles and Practice, 3rd ed, pp 671-675. Philadelphia, Lippincott Williams & Wilkins, 2001.
9. Theisen J, Peters JH, Stein HJ: Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus. World J Surg 27:1018-1020, 2003.
10. Souza RF, Shewmake K, Pearson S, et al: Acid increases proliferatrion via ERK and p38 MAPK-mediated increases in cyclo-oxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 287:743-748, 2004.
11. Hamoui N, Peters J, Schneider S, et al: Increased acid exposure in patients with gastroesophageal reflux disease influences cyclo-oxygenase-2 gene expression in the squamous epithelium of the lower esophagus. Arch Surg 139:712-717, 2004.
12. Jenkins GJS, D'Souza FR, Suzen SH et al: Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: The potential role of antioxidants in Barrett's esophagus. Carcinogenesis 28:136-142, 2007.
13. Hameeteman W, Tytgat GN, Houthoff HJ, et al: Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 96:1249-1256, 1989.
14. Raja S, Finkelstein SD, Bakash FK, et al: Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus. Ann Thorac Surg 72:1130-1135, 2001.
15. Spechler SJ, Zeroogian JM, Antonioli DA, et al: Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 344:1533-1536, 1994.
16. Pera M: Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 27: 999-1008, 2003.
17. Castell DO: Medical, surgical and endoscopic treatment of gastoresophageal reflux disease and Barrett's esophagus. J Clin Gastroenterol 33:262-266, 2001.
18. Katz PO, Anderson C, Khouri R, et al: Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther 1998;12:1231-1234, 1998.
19. Peters FTM, Ganesh S, Kuipers EJ, et al: Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomized double-blind study. Gut 45:489-494, 1999.
20. Malesci A, Savarino V, Zentilin P, et al: Partial regression of Barrett's esophagus by long-term therapy with high dose omeprazole. Gastrointest Endosc 44:700-705, 1996.
21. Correa P: Human gastric carcinogenesis: A multi-step and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 52:6735,1992.
22. Haigh CR, Attwood SE, Thompson DG, et al: Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 124:615-625, 2003.
23. Wetscher GJ, Hinder RA, Smyrk T, et al: Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 44:1132-1135, 1999.
24. Chow WH, Finkle WD, McLaughlin JK, et al: The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 274:474-477, 1995.
25. Bateman DN, Colin-Jones D, Hartz S, et al: Mortality study of 18,000 patients treated with omeprazole. Gut 52:942-946, 2003.
26. Ye W, Chow WH, Lagergren J, et al: Risk of adenocarcinoma of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases after antireflux surgery. Gastroenterology 121:1286-1293, 2001.
27. Spechler SJ, Lee E, Ahnen D, et al: Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial. JAMA 285:2331-2338, 2001.
28. Weimin YE, Chow WH, Lagergren J, et al: Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 121:1286-1293, 2001.
29. Corey KE, Schmitz SM, Shaheen NJ: Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol 98:2390-2394, 2003.
30. McDonald ML, Trastek VF, Allen MS, et al: Barrett's esophagus: Does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg 111:1135-1140, 1996.
31. Cameron AJ: Management of Barrett's esophagus. Mayo Clin Proc 73:457-461, 1998.
32. Katz D, Rothstein R, Schned A, et al: The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 93:536-541, 1998.
33. Hofstetter WL, Peters JH, DeMeester TR, et al: Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 234:532-538, 2001.
34. Ortiz A, DeHaro LFM, Parrilla P, et al: Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study. Br J Surg 83:274-278, 1996.
35. Gurski RR, Peters JH, Hagen JA, et al: Barrett's esophagus can and does regress after antireflux surgery: A study of prevalence and predictive features. J Am Coll Surg 196:706-713, 2003.
36. Oelschlager BK, Barreca M, Chang L, et al: Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Thorac Surg 238: 458 466, 2003.
37. Rice TW, Sontag SJ, Lightdale CJ: Esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 101: 2177-2184, 2006.
38. Reid BJ, Blount PL, Feng Z, et al: Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 95: 3089-3096, 2000.
39. Buttar NS, Wang KK, Sebo TJ, et al: Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120:1607-1619, 2001.
40. Schnell T, Sontag SJ, Chejfec G, et al: Long-term non-surgical management of Barrett's esophagus with high-grade dysplasia. Gasteroenterology 120:1607-1619, 2001.
41. Dar MS, Goldblum JR, Rice TW, et al: Can extent of high-grade dysplasia in Barrett's esophagus predict the presence of adenocarcinoma at oesophagectomy? Gut 52:486-189, 2003.
42. Schuchert MJ, McGrath K, Buenaventura PO: Barrett's esophagus: Diagnostic approaches and surveillance. Semin Thorac Cardiovasc Surg 17:301-312, 2005.
43. Wang KK: Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 49:S20-S23, 1999.
44. Overholt BF, Lightdale C, Wang KK, et al: Photodynamic therapy with porfimer sodium for ablation of high grade dysplasia in Barrett's esophagus: International, partially blinded, randomized phase III trial. Gastrointest Endosc 62:488-498, 2005.
45. Schuchert MJ, Luketich JD: Barrett's esophagus - emerging concepts and controversies. J Surg Oncol 95:185-189, 2007.
46. Abbas G, Pennathur A, Keeley SB, et al: Laser ablation therapies for Barrett's esophagus. Semin Thorac Cardiovasc Surg 17:313-319, 2005.
47. Panjehpour M, Overholt BF, Haydek JM, et al: Results of photodynamic for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 95:2177-2184, 2000.
48. Sharma VK, Wang KK, Overholt BF, et al: Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65:185-95, 2007.
49. Hazey JW, Dunkin BJ, Melvin WS: Changing attitudes toward endoluminal therapy. Surg Endosc 21:445-448, 2007.
50. Seewald S, Akaraviputh T, Seitz U, et al: Circumferential EMR and complete removal of Barrett's epithelium: A new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57:854-859, 2003.
51. Giovannini M, Bories E, Pesenti C, et al: Circumferential endoscopic mucosal resection in Barrett's esophagus with high grade intraepithelial neoplasia or mucosal cancer: Preliminary results in 21 patients. Endoscopy 36:782-787, 2004.
52. May A, Gossner L, Pech O, et al: Local endoscopic therapy for intra-epithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: Acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14:1085-1091, 2002.
53. Buttar NS, Wang KK, Lutzke LS, et al: Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastroinest Endosc 54:682-688, 2001.
54. Ell C, May A, Pech O, et al: Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 65:3-10, 2007.
55. Lopes CV, Hela M, Pesenti C, et al: Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc 21:820-824, 2007.
56. Swisher SG, Deford L, Merriman KW, et al: Effects of operative volume on morbidity, mortality and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 119:1126-1132, 2000.
57. Luketich JD, Nguyen NT, Schauer P: Laparoscopic transhiatal esophagectomy for Barrett's esophagus with high-grade dysplasia. J Soc Lap Surg 2:75-77, 1998.
58. Pierre AF, Luketich JD. Technique and role of minimally invasive esophagectomy for premalignant and malignant diseases of the esophagus. Surg Oncol Clin N Am 11:337-350, 2002.
59. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al: Minimally-invasive esophagectomy: Outcomes in 222 patients. Ann Surg 238:486-494, 2003.
60. Nguyen NT, Schauer P, Luketich JD: Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery 127:284-290, 2000.
61. Pennathur A, Landreneau RJ, Luketich JD: Surgical aspects of the patient with high-grade dysplasia. Semin Thorac Cardiovasc Surg 17:326-332, 2005.
62. Sampliner RE: Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 97:1888-1895, 2002.